Albumin Market

Albumin (as Excipient) Market (Product - Human Serum Albumin, Recombinant Albumin; Application - Human Serum Albumin Applications ( Drug Formulation, Drug Delivery, Vaccines, Medical Device Coating, Culture Medium & Stabilizer, Diagnostics, In Vitro Fertilization), Recombinant Albumin Applications, Serum Albumin Applications (Drug Formulation, Drug Delivery, Vaccines, Medical Device Coating, Culture Medium & Stabilizer, Diagnostics, In Vitro Fertilization); End use - Pharmaceutical & Biotechnology Industry, Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026

  • Rep Id : TMRGL3984
  • Published On : Jul 2018
  • No. of Pages : 212
  • Category : Pharmaceutical

1. Preface
   1.1. Market Definition and Scope
   1.2. Market Segmentation
   1.3. Key Research Objectives
   1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Albumin (as Excipient) Market

4. Market Overview
   4.1. Introduction
        4.1.1. Product Type Definition
        4.1.2. Industry Evolution / Developments
   4.2. Overview
   4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
   4.4. Global Albumin (as Excipient) Market Analysis and Forecast, 2016–2026
        4.4.1. Market Revenue Projections (US$ Mn)
        4.4.2. Market Volume Shipments Projections
   4.5. Porter’s Five Force Analysis

5. Market Outlook
   5.1. Key Trends
   5.2. Competition Landscape Analysis (Based on Recent Developments of Key Players)
   5.3. Pricing Assessment, by Product Type

6. Global Albumin (as Excipient) Market Analysis and Forecast, by Product Type
   6.1. Introduction & Definition
   6.2. Key Findings / Developments
   6.3. Market Value and Volume Forecast, by Product Type, 2016–2026
        6.3.1. Human Serum Albumin
        6.3.2. Recombinant Albumin
   6.4. Market Attractiveness, by Product Type

7. Global Albumin (as Excipient) Market Analysis and Forecast, by Application
   7.1. Introduction & Definition
   7.2. Key Findings / Developments
   7.3. Market Value and Volume Forecast, by Application, 2016–2026
        7.3.1. Human Serum Albumin Applications
               7.3.1.1. Drug Formulation
               7.3.1.2. Drug Delivery
               7.3.1.3. Vaccines
               7.3.1.4. Medical Device Coating
               7.3.1.5. Culture Media & Stabilizers
               7.3.1.6. Diagnostics
               7.3.1.7. In Vitro Fertilization
        7.3.2. Recombinant Albumin Applications
               7.3.2.1. Drug Formulation
               7.3.2.2. Drug Delivery
               7.3.2.3. Vaccines
               7.3.2.4. Medical Device Coating
               7.3.2.5. Culture Media & Stabilizers
               7.3.2.6. Diagnostics
               7.3.2.7. In Vitro Fertilization
   7.4. Market Attractiveness, by Application

8. Global Albumin (as Excipient) Market Analysis and Forecast, by End-user
   8.1. Introduction & Definition
   8.2. Key Findings / Developments
   8.3. Market Value Forecast, by End-user, 2016–2026
        8.3.1. Pharmaceutical & Biotechnology Industry
        8.3.2. Research Institutes
        8.3.3. Others
   8.4. Market Attractiveness, by End-user

9. Global Albumin (as Excipient) Market Analysis and Forecast, by Region
   9.1. Key Findings
   9.2. Market Value and Volume Forecast, by Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Rest of the World
   9.3. Market Attractiveness, by Country/Region

10. North America Albumin (as Excipient) Market Analysis and Forecast
   10.1. Introduction
        10.1.1. Key Findings
   10.2. Market Value and Volume Forecast, by Product Type, 2016–2026
        10.2.1. Human Serum Albumin
        10.2.2. Recombinant Albumin
   10.3. Market Value and Volume Forecast, by Application, 2016–2026
        10.3.1. Human Serum Albumin Applications
               10.3.1.1. Drug Formulation
               10.3.1.2. Drug Delivery
               10.3.1.3. Vaccines
               10.3.1.4. Medical Device Coating
               10.3.1.5. Culture Media & Stabilizers
               10.3.1.6. Diagnostics
               10.3.1.7. In Vitro Fertilization
        10.3.2. Recombinant Albumin Applications
               10.3.2.1. Drug Formulation
               10.3.2.2. Drug Delivery
               10.3.2.3. Vaccines
               10.3.2.4. Medical Device Coating
               10.3.2.5. Culture Media & Stabilizers
               10.3.2.6. Diagnostics
               10.3.2.7. In Vitro Fertilization
   10.4. Market Value Forecast, by End-user, 2016–2026
        10.4.1. Pharmaceutical & Biotechnology Industry
        10.4.2. Research Institutes
        10.4.3. Others
   10.5. Market Value and Volume Forecast, by Country, 2016–2026
        10.5.1. U.S.
        10.5.2. Canada
   10.6. Market Attractiveness Analysis
        10.6.1. by Product Type
        10.6.2. by Application
        10.6.3. by End-user
        10.6.4. by Country

11. Europe Albumin (as Excipient) Market Analysis and Forecast
   11.1. Introduction
        11.1.1. Key Findings
   11.2. Market Value and Volume Forecast, by Product Type, 2016–2026
        11.2.1. Human Serum Albumin
        11.2.2. Recombinant Albumin
   11.3. Market Value and Volume Forecast, by Application, 2016–2026
        11.3.1. Human Serum Albumin Applications
               11.3.1.1. Drug Formulation
               11.3.1.2. Drug Delivery
               11.3.1.3. Vaccines
               11.3.1.4. Medical Device Coating
               11.3.1.5. Culture Media & Stabilizers
               11.3.1.6. Diagnostics
               11.3.1.7. In Vitro Fertilization
        11.3.2. Recombinant Albumin Applications
               11.3.2.1. Drug Formulation
               11.3.2.2. Drug Delivery
               11.3.2.3. Vaccines
               11.3.2.4. Medical Device Coating
               11.3.2.5. Culture Media & Stabilizers
               11.3.2.6. Diagnostics
               11.3.2.7. In Vitro Fertilization
   11.4. Market Value Forecast, by End-user, 2016–2026
        11.4.1. Pharmaceutical & Biotechnology Industry
        11.4.2. Research Institutes
        11.4.3. Others
   11.5. Market Value and Volume Forecast, by Country, 2016–2026
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Spain
        11.5.5. Italy
        11.5.6. Rest of Europe
   11.6. Market Attractiveness Analysis
        11.6.1. by Product Type
        11.6.2. by Application
        11.6.3. by End-user
        11.6.4. by Country

12. Asia Pacific Albumin (as Excipient) Market Analysis and Forecast
   12.1. Introduction
        12.1.1. Key Findings
   12.2. Market Value and Volume Forecast, by Product Type, 2016–2026
        12.2.1. Human Serum Albumin
        12.2.2. Recombinant Albumin
   12.3. Market Value and Volume Forecast, by Application, 2016–2026
        12.3.1. Human Serum Albumin Applications
               12.3.1.1. Drug Formulation
               12.3.1.2. Drug Delivery
               12.3.1.3. Vaccines
               12.3.1.4. Medical Device Coating
               12.3.1.5. Culture Media & Stabilizers
               12.3.1.6. Diagnostics
               12.3.1.7. In Vitro Fertilization
        12.3.2. Recombinant Albumin Applications
               12.3.2.1. Drug Formulation
               12.3.2.2. Drug Delivery
               12.3.2.3. Vaccines
               12.3.2.4. Medical Device Coating
               12.3.2.5. Culture Media & Stabilizers
               12.3.2.6. Diagnostics
               12.3.2.7. In Vitro Fertilization
   12.4. Market Value Forecast, by End-user, 2016–2026
        12.4.1. Pharmaceutical & Biotechnology Industry
        12.4.2. Research Institutes
        12.4.3. Others
   12.5. Market Value and Volume Forecast, by Country, 2016–2026
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
   12.6. Market Attractiveness Analysis
        12.6.1. by Product Type
        12.6.2. by Application
        12.6.3. by End-user
        12.6.4. by Country

13. Rest of the World Albumin (as Excipient) Market Analysis and Forecast
   13.1. Introduction
        13.1.1. Key Findings
   13.2. Market Value and Volume Forecast, by Product Type, 2016–2026
        13.2.1. Human Serum Albumin
        13.2.2. Recombinant Albumin
   13.3. Market Value and Volume Forecast by Application, 2016–2026
        13.3.1. Human Serum Albumin Applications
               13.3.1.1. Drug Formulation
               13.3.1.2. Drug Delivery
               13.3.1.3. Vaccines
               13.3.1.4. Medical Device Coating
               13.3.1.5. Culture Media & Stabilizers
               13.3.1.6. Diagnostics
               13.3.1.7. In Vitro Fertilization
        13.3.2. Recombinant Albumin Applications
               13.3.2.1. Drug Formulation
               13.3.2.2. Drug Delivery
               13.3.2.3. Vaccines
               13.3.2.4. Medical Device Coating
               13.3.2.5. Culture Media & Stabilizers
               13.3.2.6. Diagnostics
               13.3.2.7. In Vitro Fertilization
   13.4. Market Value Forecast, by End-user, 2016–2026
        13.4.1. Pharmaceutical & Biotechnology Industry
        13.4.2. Research Institutes
        13.4.3. Others
   13.6. Market Attractiveness Analysis
        13.6.1. by Product Type
        13.6.2. by Application
        13.6.3. by End-user

14. Competition Landscape
   14.1. Market Player – Competition Matrix (by Tier and Size of Companies)
   14.2. Market Share Analysis, by Company (2017)
   14.3. Company Profiles
        14.3.1. Albumedix A/S (Novozyme A/S)
               14.3.1.1. Overview (HQ, Employee Strength, Business Segments)
               14.3.1.2. Financials
               14.3.1.3. Recent Developments
               14.3.1.4. Strategy
        14.3.2. Albumin Therapeutics, LLC
               14.3.2.1. Overview (HQ, Employee Strength, Business Segments)
               14.3.2.2. Financials
               14.3.2.3. Recent Developments
               14.3.2.4. Strategy
        14.3.3. Biotest AG
               14.3.3.1. Overview (HQ, Employee Strength, Business Segments)
               14.3.3.2. Financials
               14.3.3.3. Recent Developments
               14.3.3.4. Strategy
        14.3.4. CSL Behring LLC
               14.3.4.1. Overview (HQ, Employee Strength, Business Segments)
               14.3.4.2. Financials
               14.3.4.3. Recent Developments
               14.3.4.4. Strategy
        14.3.5. Grifols International, S.A
               14.3.5.1. Overview (HQ, Employee Strength, Business Segments)
               14.3.5.2. Financials
               14.3.5.3. Recent Developments
               14.3.5.4. Strategy
        14.3.6. HiMedia Laboratories Pvt. Ltd.
               14.3.6.1. Overview (HQ, Employee Strength, Business Segments)
               14.3.6.2. Financials
               14.3.6.3. Recent Developments
               14.3.6.4. Strategy
        14.3.7. InVitria
               14.3.7.1. Overview (HQ, Employee Strength, Business Segments)
               14.3.7.2. Financials
               14.3.7.3. Recent Developments
               14.3.7.4. Strategy
        14.3.8. Medxbio Pte Ltd.
               14.3.8.1. Overview (HQ, Employee Strength, Business Segments)
               14.3.8.2. Financials
               14.3.8.3. Recent Developments
               14.3.8.4. Strategy
        14.3.9. Octapharma AG
               14.3.9.1. Overview (HQ, Employee Strength, Business Segments)
               14.3.9.2. Financials
               14.3.9.3. Recent Developments
               14.3.9.4. Strategy
        14.3.10. RayBiotech, Inc.
               14.3.10.1. Overview (HQ, Employee Strength, Business Segments)
               14.3.10.2. Financials
               14.3.10.3. Recent Developments
               14.3.10.4. Strategy
        14.3.11. SeraCare Life Sciences
               14.3.11.1. Overview (HQ, Employee Strength, Business Segments)
               14.3.11.2. Financials
               14.3.11.3. Recent Developments
               14.3.11.4. Strategy
        14.3.12. Sigma-Aldrich Co. (Merck KGaA)
               14.3.12.1. Overview (HQ, Employee Strength, Business Segments)
               14.3.12.2. Financials
               14.3.12.3. Recent Developments
               14.3.12.4. Strategy

List of Tables

Table 01: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 02: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Product, 2016–2026
Table 03: Global Albumin (as Excipient) Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 04: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Application (Human Serum Albumin Applications), 2016–2026
Table 05: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Application (Human Serum Albumin Applications), 2016–2026
Table 06: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Application (Recombinant Albumin Applications), 2016–2026
Table 07: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Application (Recombinant Albumin Applications), 2016–2026
Table 08: Global Albumin (as Excipient) Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 09: Global Albumin (as Excipient) Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 10: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Region, 2016–2026
Table 11: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 12: North America Albumin (as Excipient) Market Volume (kg) Forecast, by Country, 2016–2026
Table 13: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 14: North America Albumin (as Excipient) Market Volume (Kg) Forecast, by Product, 2016–2026
Table 15: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 16: North America Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 17: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 18: North America Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 19: North America Albumin (as Excipient) Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 20: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 21: Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Country/Sub-region, 2016–2026
Table 22: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 23: Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Product, 2016–2026
Table 24: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 25: Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 26: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 27: Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 28: Europe Albumin (as Excipient) Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 29: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 30: Asia Pacific Albumin (as Excipient) Market Volume (kg) Forecast, by Country/Sub-region, 2016–2026
Table 31: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 32: Asia Pacific Albumin (as Excipient) Market Volume (Kg) Forecast, by Product, 2016–2026
Table 33: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 34: Asia Pacific Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 35: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 36: Asia Pacific Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 37: Asia Pacific Albumin (as Excipient) Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 38: Rest of the World Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 39: Rest of the World Albumin (as Excipient) Market Volume (Kg) Forecast, by Product, 2016–2026
Table 40: Rest of the World Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 41: Rest of the World Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 42: Rest of the World Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 43: Rest of the World Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 44: Rest of the World Albumin (as Excipient) Market Size (US$ Mn) Forecast, by End-user, 2016–2026

 

List of Figures

Figure 01: Global Albumin (as Excipient) Market Size (US$ Mn) Forecast, 2016–2026
Figure 02: Global Albumin (as Excipient) Market Volume (Kg) Forecast, 2016–2026
Figure 03: Global Albumin (as Excipient) Market Value Share, by Product, 2017 and 2026
Figure 04: Global Albumin (as Excipient) Market Attractiveness, by Product, 2018–2026
Figure 05: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Human Serum Albumin, 2016–2026
Figure 06: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Recombinant Albumin, 2016–2026
Figure 07: Global Albumin (as Excipient) Market Value Share, by Application, 2017 and 2026
Figure 08: Global Albumin (as Excipient) Market Attractiveness, by Application, 2018–2026
Figure 09: Global Albumin (as Excipient) Market Value Share, by Application (Human Serum Albumin), 2017 and 2026
Figure 10: Global Albumin (as Excipient) Market Attractiveness, by Application (Recombinant Albumin), 2017 and 2026
Figure 11: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drug Formulation, 2016–2026
Figure 12: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drug Delivery, 2016–2026
Figure 13: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vaccines, 2016–2026
Figure 14: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Medical Device Coating, 2016–2026
Figure 15: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Culture Media & Stabilizers, 2016–2026
Figure 16: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostics, 2016–2026
Figure 17: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by In Vitro Fertilization, 2016–2026
Figure 18: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drug Formulation, 2016–2026
Figure 19: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drug Delivery, 2016–2026
Figure 20: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vaccines, 2016–2026
Figure 21: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Medical Device Coating, 2016–2026
Figure 22: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Culture Media & Stabilizers, 2016–2026
Figure 23: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostics, 2016–2026
Figure 24: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by In Vitro Fertilization, 2016–2026
Figure 25: Global Albumin (as Excipient) Market Attractiveness, by Application (Human Serum Albumin), 2018 - 2026
Figure 26: Global Albumin (as Excipient) Market Attractiveness, by Application (Recombinant Albumin), 2018–2026
Figure 27: Global Albumin (as Excipient) Market Value Share, by End-user, 2017 and 2026
Figure 28: Global Albumin (as Excipient) Market Attractiveness, by End-user, 2018–2026
Figure 29: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Industry, 2016–2026
Figure 30: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Research Institutes, 2016–2026
Figure 31: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Others, 2016–2026
Figure 32: Global Albumin (as Excipient) Market Value Share Analysis, by Region, 2017 and 2026
Figure 33: Global Albumin (as Excipient) Market Attractiveness Analysis, by Region
Figure 34: North America Albumin (as Excipient) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 35: North America Albumin (as Excipient) Market Value Share, by Country, 2017 and 2026
Figure 36: North America Albumin (as Excipient) Market Attractiveness, by Country, 2018–2026
Figure 37: North America Albumin (as Excipient) Market Value Share, by Product, 2017 and 2026
Figure 38: North America Albumin (as Excipient) Market Attractiveness, by Product, 2018–2026
Figure 39: North America Albumin (as Excipient) Market Value Share, by Human Serum Albumin Application, 2017 and 2026
Figure 40: North America Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Application, 2018–2026
Figure 41: North America Albumin (as Excipient) Market Value Share, by Recombinant Albumin Application, 2017 and 2026
Figure 42: North America Albumin (as Excipient) Market Attractiveness, by Recombinant Albumin Application, 2018–2026
Figure 43: North America Albumin (as Excipient) Market Value Share, by End-user, 2017 and 2026
Figure 44: North America Albumin (as Excipient) Market Attractiveness, by End-user, 2018–2026
Figure 45: Europe Albumin (as Excipient) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 46: Europe Albumin (as Excipient) Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 47: Europe Albumin (as Excipient) Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 48: Europe Albumin (as Excipient) Market Value Share, by Product, 2017 and 2026
Figure 49: Europe Albumin (as Excipient) Market Attractiveness, by Product, 2018–2026
Figure 50: Europe Albumin (as Excipient) Market Value Share, by Human Serum Albumin Applications, 2017 and 2026
Figure 51: Europe Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Applications, 2018–2026
Figure 52: Europe Albumin (as Excipient) Market Value Share, by Recombinant Albumin Applications, 2017 and 2026
Figure 53: Europe Albumin (as Excipient) Market Attractiveness, by Recombinant Albumin Applications, 2018–2026
Figure 54: Europe Albumin (as Excipient) Market Value Share, by End-user, 2017 and 2026
Figure 55: Europe Albumin (as Excipient) Market Attractiveness, by End-user, 2018–2026
Figure 56: Asia Pacific Albumin (as Excipient) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 57: Asia Pacific Albumin (as Excipient) Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 58: Asia Pacific Albumin (as Excipient) Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 59: Asia Pacific Albumin (as Excipient) Market Value Share, by Product, 2017 and 2026
Figure 60: Asia Pacific Albumin (as Excipient) Market Attractiveness, by Product, 2018–2026
Figure 61: Asia Pacific Albumin (as Excipient) Market Value Share, by Human Serum Albumin Applications, 2017 and 2026
Figure 62: Asia Pacific Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Applications, 2018–2026
Figure 63: Asia Pacific Albumin (as Excipient) Market Value Share, by Recombinant Albumin Applications, 2017 and 2026
Figure 64: Asia Pacific Albumin (as Excipient) Market Attractiveness, by Recombinant Albumin Applications, 2018–2026
Figure 65: Asia Pacific Albumin (as Excipient) Market Value Share, by End-user, 2017 and 2026
Figure 66: Asia Pacific Albumin (as Excipient) Market Attractiveness, by End-user, 2018–2026
Figure 67: Rest of the World Albumin (as Excipient) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 68: Rest of the World Albumin (as Excipient) Market Value Share, by Product, 2017 and 2026
Figure 69: Rest of the World Albumin (as Excipient) Market Attractiveness, by Product, 2018–2026
Figure 70: Rest of the World Albumin (as Excipient) Market Value Share, by Human Serum Albumin Applications, 2017 and 2026
Figure 71: Rest of the World Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Applications, 2018–2026
Figure 72: Rest of the World Albumin (as Excipient) Market Value Share, by Recombinant Albumin Applications, 2017 and 2026
Figure 73: Rest of the World Albumin (as Excipient) Market Attractiveness, by Recombinant Albumin Applications, 2018–2026
Figure 74: Rest of the World Albumin (as Excipient) Market Value Share, by End-user, 2017 and 2026
Figure 75: Rest of the World Albumin (as Excipient) Market Attractiveness, by End-user, 2018–2026
  

.